Spero Therapeutics, Inc. (SPRO) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Spero Therapeutics, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | 15.23x | -0.81x | 3.40x | -1.40x | -5.51x | -5.55x |
| P/B Ratio | 2.21x | 1.21x | 0.72x | 0.86x | 5.60x | 3.29x |
| P/S Ratio | 2.19x | 1.16x | 0.75x | 1.34x | 161.12x | 46.52x |
| Profitability | ||||||
| Gross Margin | 100.0% | -101.7% | 50.4% | 100.0% | 100.0% | -618.1% |
| Operating Margin | -0.0% | -152.9% | 20.7% | -86.9% | -2865.5% | -847.9% |
| Net Margin | 14.4% | -142.9% | 22.0% | -95.5% | -2923.6% | -839.0% |
| EBITDA Margin | -0.0% | -151.1% | 26.2% | -88.4% | -2839.4% | -839.8% |
| Liquidity | ||||||
| Current Ratio | 7.59x | 2.19x | 3.53x | 5.04x | 8.46x | 9.70x |
| Quick Ratio | 7.59x | 2.19x | 3.53x | 5.25x | 8.46x | 9.70x |
| Leverage | ||||||
| Debt/Equity | 0.05x | 0.09x | 0.05x | 0.09x | 0.08x | 0.06x |
YoY = year-over-year change. Source: FMP..